ClinicalTrials.gg
CompletedNCT02677168cNEPUpdated Apr 18, 2018

cNEP for the Treatment of Obstructive Sleep Apnea

An interventional study of cNEP in Sleep Apnea, Obstructive, sponsored by Sommetrics, Inc.. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-04-18.

Sponsored by Sommetrics, Inc. · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
71
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine whether cNEP (continuous positive external pressure) is effective in treating obstructive sleep apnea

02

Conditions studied

  • Sleep Apnea, Obstructive

Keywords

  • obstructive sleep apnea
  • sleep apnea
  • OSA
  • cNEP
  • continuous negative external pressure
03

In context

Sleep Apnea, Obstructive

2,240 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.

This study's enrollment of 71 is above the median of 52 across 1,472 interventional studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

Sommetrics, Inc. is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  • PSG performed within the previous twelve months that documents the presence of obstructive sleep apnea (the "qualifying PSG")
  • on that PSG, AHI must be 10 - 50/hr and >80% of the apneas and hypopneas must be obstructive
  • no significant changes in health, medications, or lifestyle since the qualifying PSG

Key Exclusion Criteria:

  • previous major surgery, injury or radiation to the neck
  • beard or excessive hair on the area of the neck where the collar will be applied
  • carotid artery disease
  • serious medical conditions
  • pregnancy
  • use of home oxygen
  • silicone allergy
  • sleep disturbance other than obstructive sleep apnea
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
71 participants (actual)

Study arms

  • Experimental
    cNEP

    Subjects with OSA will be treated with cNEP (continuous negative external pressure) at home for three weeks

    Device: cNEP

Interventions

  • DevicecNEP

    continuous negative external pressure

06

What researchers measure

Primary outcomes

  1. "Sustained Response" of reduction of AHI (apnea hypopnea index) at PSG (polysomnography) II

    A response (either initial or sustained) is defined as an AHI that is \< 50% of the qualifying PSG (polysomnography) that is also \< 15/hr

    Time frame: three weeks--PSG II will be done after three weeks of home use of cNEP following PSG I

  2. occurrence of adverse events

    Adverse events that occur during the three weeks of cNEP home use.

    Time frame: three weeks

Secondary outcomes

  1. "Initial Response" of AHI at PSG I

    An AHI (apnea hypopnea index) that is \<50% of that of the qualifying PSG, and \<15/hr at PSG I, with cNEP in place.

    Time frame: up to 12 months after the qualifying PSG

  2. Comparison of AHI at PSG I and PSG II

    The AHI determined at PSG II will be compared with that of PSG I

    Time frame: three weeks

  3. time of SpO2 (oxygen saturation) < 90%

    the number of minutes during the overnight PSG when SpO2 is \< 90% with cNEP in place

    Time frame: during each of the overnight PSGs

  4. hours of home use of cNEP per night

    the number of hours of each night at home that the subject uses cNEP

    Time frame: three weeks after initiation of home cNEP

  5. Three CGI (clinical global impression) subjective measures

    Seven-item Likert CGI scales of three subjective measures: 1) subject's view of cNEP vs CPAP, 2) overall satisfaction with cNEP, 3) bed partner's feelings about cNEP.

    Time frame: three weeks after the initiation of home cNEP

07

Study locations

1 site
  • Toronto Sleep Institute
    Toronto, Ontario M4P 1P2, Canada
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02677168
Lead sponsor
Sommetrics, Inc.
Responsible party
Sponsor
First posted
Feb 9, 2016
Start date
May 2016
Primary completion
Nov 3, 2017
Completion
Nov 3, 2017
Last update
Apr 18, 2018

Study contacts

Adam Blackman, MD
principal investigator · Toronto Sleep Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion